Market Closed -
OTC Markets
14:04:11 2024-05-02 EDT
|
5-day change
|
1st Jan Change
|
0.0249
USD
|
+17.45%
|
|
-.--%
|
-20.19%
|
Fiscal Period: October |
2021
|
2022
|
2023
|
---|
Capitalization
1 |
45.47
|
3.745
|
0.7173
|
Enterprise Value (EV)
1 |
45.9
|
6.331
|
3.717
|
P/E ratio
|
-10.2
x
|
-1.05
x
|
-0.47
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
EV / EBITDA
|
-10,623,348
x
|
-1,224,541
x
|
-392,977
x
|
EV / FCF
|
-
|
-3,953,563
x
|
-769,525
x
|
FCF Yield
|
-
|
-0%
|
-0%
|
Price to Book
|
-669
x
|
-1.06
x
|
-0.14
x
|
Nbr of stocks (in thousands)
|
45,933
|
46,817
|
47,817
|
Reference price
2 |
0.9900
|
0.0800
|
0.0150
|
Announcement Date
|
2/28/22
|
4/28/23
|
3/4/24
|
Fiscal Period: October |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-4.281
|
-3.059
|
-1.825
|
EBIT
1 |
-0.002535
|
-0.000694
|
-4.292
|
-3.063
|
-1.829
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-0.002535
|
-0.000694
|
-4.536
|
-3.697
|
-1.518
|
Net income
1 |
-0.002535
|
-0.000694
|
-4.367
|
-3.567
|
-1.518
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.001486
|
-0.000098
|
-0.0971
|
-0.0764
|
-0.0321
|
Free Cash Flow
|
-
|
-
|
-
|
-0.9473
|
-0.9321
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/1/20
|
12/1/20
|
2/28/22
|
4/28/23
|
3/4/24
|
Fiscal Period: October |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
|
-
|
-
|
0.42
|
2.59
|
3
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-0.0989
x
|
-0.8454
x
|
-1.644
x
|
Free Cash Flow
|
-
|
-
|
-
|
-0.95
|
-0.93
|
ROE (net income / shareholders' equity)
|
-
|
31.9%
|
7,184%
|
198%
|
35.7%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-201%
|
-115%
|
-157%
|
Assets
1 |
-
|
-
|
2.174
|
3.097
|
0.9639
|
Book Value Per Share
2 |
-0
|
-0
|
-0
|
-0.0800
|
-0.1000
|
Cash Flow per Share
|
-
|
-
|
0.0400
|
0
|
0
|
Capex
|
-
|
-
|
0.04
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/1/20
|
12/1/20
|
2/28/22
|
4/28/23
|
3/4/24
|
|
1st Jan change
|
Capi.
|
---|
| +18.72% | 125B | | +14.19% | 108B | | -4.93% | 24.21B | | +3.23% | 22.78B | | -10.44% | 17.96B | | -41.74% | 16.43B | | -13.31% | 16.37B | | +2.44% | 13.58B | | +27.89% | 11.66B |
Bio Therapeutic Drugs
|